ABBV
46
-4
MDLZ
32
4
EW
57
2
ALLE
60
-4
MAR
77
3
PBI
55
2
MAS
60
2
MS
76
2
ORCL
39
6
FITB
65
-5
DE
50
-5
FE
53
-2
TDC
88
4
NEM
78
2
MHK
59
10
ED
49
-3
ETR
54
7
A
53
2
BXP
38
4
EL
74
6
ABBV
46
-4
MDLZ
32
4
EW
57
2
ALLE
60
-4
MAR
77
3
PBI
55
2
MAS
60
2
MS
76
2
ORCL
39
6
FITB
65
-5
DE
50
-5
FE
53
-2
TDC
88
4
NEM
78
2
MHK
59
10
ED
49
-3
ETR
54
7
A
53
2
BXP
38
4
EL
74
6
Financhill
Back

Bio-Rad Laboratories, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
47

BIO
Bio-Rad Laboratories, Inc.

Last Price:
$323.73
Seasonality Move:
5.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Bio-Rad Laboratories, Inc. Stock Forecast

  • Over the next 52 weeks, Bio-Rad Laboratories, Inc. has on average historically risen by 16.7% based on the past 45 years of stock performance.
  • Bio-Rad Laboratories, Inc. has risen higher in 29 of those 45 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.44%
  • Is Bio-Rad Laboratories, Inc. Stock Undervalued?
    The current Bio-Rad Laboratories, Inc. [BIO] share price is $323.82. The Score for BIO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Bio-Rad Laboratories, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Bio-Rad Laboratories, Inc. has on average historically risen by 16.7% based on the past 45 years of stock performance.

Bio-Rad Laboratories, Inc. Stock Rating

Sell
47
Bio-Rad Laboratories, Inc. (BIO) is a Sell

Is Bio-Rad Laboratories, Inc. overpriced?

  • Bio-Rad Laboratories, Inc. has risen higher in 29 of those 45 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.44%

Bio-Rad Laboratories, Inc. Stock Price History

Is BIO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
bio-rad.com

52-Week Data

52-Week High:
373.69
52-Week Low:
211.43

Prediction Charts

Market Cap:
8.7B
Price in USD:
323.82
Volume:
191.1K
Beta:
0.90

Technical Analysis

SMA50:
312.84
SMA100:
304.45
SMA200:
274.42
52-Wk Change:
-5.97%

Stock Predictions

  • Is Bio-Rad Laboratories, Inc. stock public?
    Yes, Bio-Rad Laboratories, Inc. is a publicly traded company.
  • What is the Bio-Rad Laboratories, Inc. stock quote today?
    The Bio-Rad Laboratories, Inc. stock price is 323.82 USD today.
  • How to buy Bio-Rad Laboratories, Inc. stock online?
    You can buy Bio-Rad Laboratories, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 303.87 299.86 307.78 298.97
Dec-19 299.98 301.53 302.63 295.01
Dec-22 302.02 304.85 307.07 298.80
Dec-23 304.21 301.03 304.21 298.85
Dec-24 301.00 301.75 302.72 298.78
Dec-26 301.70 303.88 304.42 300.47
Dec-29 303.88 303.73 305.62 301.07
Dec-30 301.27 304.51 305.00 300.32
Dec-31 305.81 302.99 305.98 300.26
Jan-5 302.25 322.34 322.61 302.25
Jan-6 323.94 325.50 328.25 320.00
Jan-7 325.81 324.09 326.90 320.22
Jan-8 321.12 319.08 324.75 313.88
Jan-9 321.36 323.82 326.43 318.18

Bio-Rad Laboratories, Inc. Earnings

Bio-Rad Laboratories, Inc. Earnings Report: Per Share Bio-Rad Laboratories, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Bio-Rad Laboratories, Inc. Forecast Revenue Growth

Bio-Rad Laboratories, Inc. Stock Analysis: Historical quarterly revenues per share for Bio-Rad Laboratories, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $1.11 per share.

* Bio-Rad Laboratories, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.